$IMRX

$4.18▲ +4.2% YTD

5 SEC 13D/G filings tracked · Last updated Oct 2, 2026

Filing History

News

IMRX ▲ +4.2% - Immuneering Corporation

CP $4.18▲ +4.2%Oct 2, 2026 · ThinkSabio Blog

$IMRX - Immuneering to Present at the 41st Annual Meeting of the Society for Immunotherapy of Cancer (SITC)…

News

IMRX ▲ +2.1% - Immuneering Corporation

CP $4.36▲ +2.1%Sep 28, 2026 · ThinkSabio Blog

$IMRX - Immuneering Presents Data at 2026 AACR Conference on Pancreatic Cancer Supporting Atebimetinib’s Mechanisms Designed to Extend Survival in Pan…

News

IMRX ▲ +1.5% - Immuneering Corporation

CP $4.69▲ +1.5%Sep 10, 2026 · ThinkSabio Blog

$IMRX - Immuneering to Present at the AACR Conference on Pancreatic Cancer, Highlighting Atebimetinib’s Dual Mechanism for Extended Survival…

News

IMRX ▼ -0.4% - Immuneering Corporation

CP $5.00▲ -0.4%Sep 3, 2026 · ThinkSabio Blog

$IMRX - Immuneering to Participate in Upcoming Investor Conferences…

SEC 13D/G

$IMRX SEC Filing Update (28-JUL-2026) | ThinkSabio - Stocks Simplified

$4.24▼ -36.05%Jul 28, 2026 · ThinkSabio Blog

$IMRX SEC 13D/G institutional ownership filing. Healthcare sector. SEC Filing Update: #IMRX : $4.24 Sector: Healthcare | YTD: 🔽 -36.05% The SEC disclo…